Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 4/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.44 |
| ▸ | HPGD | P15428 | 3/20 | 0.44 |
| ▸ | RAB9A | P51151 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.44 |
| ▸ | GPR3 | P46089 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 4/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.39 |
| ▸ | LIMK1 | P53667 | 2/20 | 0.39 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.39 |
| ▸ | PI4KA | P42356 | 1/20 | 0.39 |
| ▸ | PI4KB | Q9UBF8 | 1/20 | 0.39 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.37 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.36 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.36 |
| ▸ | NTSR1 | P30989 | 1/20 | 0.36 |
| ▸ | TNKS | O95271 | 1/20 | 0.35 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24169837 | 1.00 | MAPT (0.44) | MAPTALDH1A1HPGDRAB9ASMN1; SMN2 | |
| SCHEMBL25852077 | 0.98 | ALDH1A1 (0.42) | MAPTALDH1A1HPGDRAB9ASMN1; SMN2 | |
| SCHEMBL21137687 | 0.98 | MAPT (0.45) | MAPTALDH1A1HPGDRAB9ASMN1; SMN2 | |
| SCHEMBL21756108 | 0.97 | ALDH1A1 (0.41) | MAPTALDH1A1HPGDRAB9ASMN1; SMN2 | |
| SCHEMBL21137704 | 0.97 | ALDH1A1 (0.41) | MAPTALDH1A1HPGDRAB9ASMN1; SMN2 | |
| SCHEMBL22352555 | 0.97 | ALDH1A1 (0.41) | MAPTALDH1A1HPGDRAB9ASMN1; SMN2 | |
| SCHEMBL24701822 | 0.97 | ALDH1A1 (0.41) | MAPTALDH1A1HPGDRAB9ASMN1; SMN2 | |
| SCHEMBL24169344 | 0.97 | ALDH1A1 (0.41) | MAPTALDH1A1HPGDRAB9ASMN1; SMN2 | |
| SCHEMBL21755979 | 0.97 | ALDH1A1 (0.41) | MAPTALDH1A1HPGDRAB9ASMN1; SMN2 | |
| SCHEMBL26573608 | 0.97 | ALDH1A1 (0.41) | MAPTALDH1A1HPGDRAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230337526-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LT MATERIALS CO.,LTD. (KR) | 2023-10-19 | — | — | US | disclosed |
| US-20230337526-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | LT MATERIALS CO.,LTD. (KR) | 2023-10-19 | — | — | US | disclosed |
| WO-2021261849-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | 엘티소재주식회사 | 2021-12-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230337526-A1 | COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | CRY1, CYP1B1, LEF1 | MAPT 720/4885ALDH1A1 22/4885HPGD 2963/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.